 |
| Source: ProtAffin AG |
The first winner was French SME Global Bioenergies,
a company which has developed processes to convert carbohydrates from renewable
resources such as agricultural waste, sugar and starch into isobutene, a
hydrocarbon which has until now only been obtained from oil. This
substance is used for biofuels, plastics and rubbers. This new way to
produce such molecules has very low associated toxicity and is less
energy-intensive than the traditional processes, contributing to the CO2
emission reduction.
The other winner was Austrian-based SME ProtAffin AG. Their advances in
therapies for inflammatory lung disease are based on processes developing
glycan-binding decoy proteins. ProtAffin plans to apply this technology
to create pharmaceutical drugs in the fields of immune-inflammatory,
neuro-inflammatory indications and oncology.
Blog by Ana I. Catarino
No comments:
Post a Comment